$Rexahn Pharmaceuticals, Inc.(RNN)$ 8-K - Current report Filed: 2018-08-30 AccNo: 0001140361-18-037339 Size: 28 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 5.07: Submission of Matters to a Vote of Security HoldersItem 9.01: Financial Statements and Exhibits 网页链接